Unifying One Verily

Today, we launched our new brand, showcasing a look and feel that signifies renewal, growth, and unification as we bring together all parts of our business under one roof – One Verily – to bring the promise of precision health to everyone, every day.

Over the last several years, we’ve rolled out a number of innovations - software, hardware, tools, and services - that have expanded the breadth and depth of solutions for drug discovery, clinical research, care management, and health financing for employers (through our wholly-owned subsidiary, Granular).

Alongside all of this work, we have been building our precision health platform—a set of capabilities that can close the gap between research and care by creating new ways for providers, payors and pharma partners to capture patient outcomes, deliver recommended actions, and connect patients to opportunities in research, all with security, privacy governance, and compliance in mind.

Through this process, we recognized that our branding at the corporate and product level wasn’t working hard enough to convey the way our solutions can and do work in concert with each other. We needed to bring the pieces together. We needed to unify.

This concept of unification is the driving idea behind our renewed identity. We call it: precision through gestalt. Which is to say that every element of the system has been carefully crafted to underscore our focus on delivering mutually reinforcing solutions that create value greater than the sum of the parts.

Our new logo, the centerpiece of the visual identity system, is the ultimate expression of the Gestalt philosophy. It brings together two distinct entities, the square and triangle, to create a new form that tells a bigger story of our ambition as a company. The square, with its exacting corners, signifies data, evidence, privacy, security and the scientific rigor at the heart of our solutions. The triangle, with its softened edges, represents humanity, care and serves as a reminder that everything we do is in service of real people facing real health challenges. As the two sides of the mark unite at a point of focus and precision, we see the “V” of Verily and the representation of a shrinking valley between research and care. Data and decision making. Privacy and personalization.

Our new brand color is also a signal of growth and renewal as we move toward a vibrant, verdant green color palette. It is inspired by nature and alignment with humanity, as we build products that enable a better, more holistic view of health in a real world setting— meeting each person where they are on their life journey. 

Unification is also at the foundation of our portfolio strategy, which is built around a core set of flagship offerings across research, care and what we call precision measures. Each plays a critical and additive role in our pursuit to deliver the promise of precision health.

Verily Viewpoint represents the integration of our research tools and services across trial recruitment, study conduct, site clinical trial management software (formerly SignalPath), longitudinal registries and our data workbench. Together, these solutions deliver an expansive view in clinical research that enables our partners to see more evidence with greater breadth, depth and generalizability—so they can develop safe, effective treatments faster.

Verily Onduo, our virtual care platform for payors, providers, care clinics, and employers is squarely focused on building personalized pathways to better health for people living with type 1 or 2 diabetes and hypertension—helping to illuminate better care decisions at the moments that matter for each patient.

Verily Numetric is our set of precision measurement solutions that sharpen our view of health to create richer, more diverse datasets to fuel medical discoveries—solutions that enable us to measure health more completely and precisely.

And coming soon, Verily Me, will be our patient/participant brand and application. Designed around the unique needs and circumstances of each user, Verily Me will provide tailored research and care experiences that fit seamlessly into life and move people toward better health.

All of this work is culminating with the launch of a completely revamped Verily.com that not only showcases our new brand, but more importantly, brings our flagship solutions to the fore and provides a rich, editorial content hub featuring the diverse and expert perspectives of our leaders. Our goal is to become a go-to source for trusted solutions and insights that are shaping the health tech landscape.

It would be an understatement to say that this a big moment for our company. We are entering our 8th year since being founded as the first of Alphabet’s “bets” and we look back on our history with great pride in what we have accomplished—from our partnership with Dexcom to deliver miniaturization technology as part of their G6 and G7 continuous glucose monitoring devices, to the launch of the clinical-grade Verily Study Watch to collect data in clinical trials, to the launch of the Project Baseline Health Study in partnership with Stanford, Duke and the California Health and Longevity Institute to better understand health and disease over time. This is the foundational work that our next chapter is built upon.

We also look forward with great optimism in what lies ahead. What excites me most is how we got here as a team. As truly, One Verily. This new expression of our brand has been shaped collaboratively by the entire organization. It has been pulled through our product interfaces, our user experiences and the way we express our culture and values. We can’t wait to continue filling it with meaning and purpose together as we enter this next exciting chapter.